Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and PK of GreenCare Cannabis Extract in Healthy Volunteers
NCT06807762Phase 1Recruiting
- Sponsor
- GreenCare Pharma
- Start
- Mar 2025
- Primary completion
- Jun 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of cannabis extract, sponsored by GreenCare Pharma. Primary endpoint: Maximum Tolerated Dose at 5 days. Started Mar 2025; status: recruiting.
02
Drugs
cannabis extract
Beyond the preview
Go deeper on NCT06807762.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06807762.